Plain-English translation of NCT07376837 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing radiofrequency ablation (RFA) as an alternative to surgery for people with small, low-risk papillary thyroid cancer. RFA is a minimally invasive procedure that uses controlled heat to destroy the cancer while preserving your thyroid gland. The goal is to determine whether this treatment can safely and effectively cure small thyroid cancers while reducing complications like voice changes and the need for lifelong medication.
Standard surgery for thyroid cancer is highly effective but can cause side effects like voice changes, calcium imbalances, prolonged recovery, and lifelong thyroid hormone replacement. Some patients avoid surgery out of concern for these complications, while others find it emotionally difficult to wait under active surveillance without treatment. This study explores whether this minimally invasive heat treatment could offer a safer middle ground for carefully selected patients.
You likely qualify if…
You likely don't qualify if…
You will have one outpatient radiofrequency ablation procedure performed under local anesthesia with light sedation, guided by ultrasound to precisely target the cancer. The procedure takes place in a hospital or clinic and you will go home the same day. After treatment, you will return for regular follow-up appointments that include physical exams, neck ultrasound scans, and blood tests to monitor your thyroid function and ensure the cancer has been eliminated.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Canada